当前位置: 首页 > 团队队伍 > 硕士生导师 > 正文

刘志洪

来源:yl34511线路中心    作者:   编辑:mc    发布日期:2023-05-26

刘志洪教授,博士生导师,永利集团官网首页健康科学与工程学院经理,永利集团官网首页分子诊断与精准治疗研究中心主任。2011年入选教育部新世纪优秀人才2016年获得国家杰出青年科学基金,2017年入选科技部创新人才推进计划2018年入选万人计划科技领军人才。研究方向为化学测量学及其生物医学应用。近年来,围绕重大疾病分子诊断与辅助治疗,创新化学测量方法,及探针、药物体内靶向输运新策略,建立了一批基于光、电传感的疾病标志分子体外快速诊断平台,发展了活体内生理、病理相关过程高时空分辨监测技术,开发针对肿瘤及脑疾病的辅助治疗新手段。已在J. Am. Chem. Soc.Angew. Chem. Int. Ed.Adv. Mater.Matter等期刊发表SCI论文150余篇,SCI他引逾5000次,参编学术专著5部。

Emailzhhliu@whu.edu.cn

Group websitehttps://webofgroup.cn/upconversionliu/#/home

Prof. Liu Zhihong, Doctoral Supervisor, Dean of College of Health Sciences and Engineering, Director of Molecular Diagnosis and Precision Therapy Research Center. He was selected as one of the "New Century Excellent Talents" by the Ministry of Education in 2011 and the "Innovative Talent Promotion Program" by the Ministry of Science and Technology in 2017. He was supported by the Outstanding Youth Science Foundation of National Natural Science Foundation in 2016. He was selected as one of the "Ten Thousand People Plan" leading talents in science and technology in 2018. His research interests include chemometrics and its biomedical applications. In recent years, focusing on molecular diagnosis and adjuvant therapy of major diseases, he has innovated chemical measurement methods, and new strategies for in vivo targeted delivery of probes and drugs, established a number of in vitro rapid diagnosis platforms for disease marker based on optical and electrochemical sensing. He also developed high spatial and temporal resolution monitoring technologies for physiological and pathology-related processes in vivo, and new adjuvant therapeutic tools for tumor and brain diseases.